Vaccinations not tested on pregnant women during trials
The European Medicines Agency is closely monitoring data emerging regarding the vaccination of pregnant women.
The news comes after Brazil suspended the use of the AstraZeneca vaccine, following the death of a pregnant woman who received the jab.
Vaccinations were not tested on pregnant women during clinical trials.
At the moment, EMA has very limited data regarding pregnant women and #COVID19vaccines. We are closely monitoring the data that is emerging. #EMAPresser
— EU Medicines Agency (@EMA_News) May 12, 2021
The HSE says no safety concerns have been raised for women or their babies.
Dr. Georgy Genov of the EMA, says the agency is keeping a close eye on the situation as more pregnant women receive vaccination:
Elsewhere, the European regulators will make a decision on the authorisation of a Covid-19 vaccine for adolescents by the end of May.
The EMA is currently reviewing an application to allow the Comirnaty inoculation, developed by Pfizer & BioNTech, to be given to children aged 12 to 15.
It is a two-dose vaccine, which is currently authorised for use in people aged 16 and older.
Dr. Marco Cavaleri says EMA officials are considering allowing younger people to receive it as well: